NGS Group Past Earnings Performance
Past criteria checks 0/6
NGS Group's earnings have been declining at an average annual rate of -77.9%, while the Healthcare industry saw earnings growing at 31.5% annually. Revenues have been declining at an average rate of 0.7% per year.
Key information
-77.9%
Earnings growth rate
-77.9%
EPS growth rate
| Healthcare Industry Growth | 8.1% |
| Revenue growth rate | -0.7% |
| Return on equity | -118.6% |
| Net Margin | -28.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
NGS Group (STO:NGS) Has Debt But No Earnings; Should You Worry?
Oct 20
NGS Group (STO:NGS) Is Making Moderate Use Of Debt
Jul 07Is NGS Group (STO:NGS) Using Too Much Debt?
Mar 30Is NGS Group (STO:NGS) Using Too Much Debt?
Nov 08NGS Group's (STO:NGS) Returns On Capital Not Reflecting Well On The Business
Sep 23NGS Group (STO:NGS) Has A Rock Solid Balance Sheet
Jul 20NGS Group's (STO:NGS) Returns On Capital Not Reflecting Well On The Business
Jun 23NGS Group (STO:NGS) Has A Pretty Healthy Balance Sheet
Sep 02Is NGS Group (STO:NGS) A Risky Investment?
May 03How Many NGS Group AB (publ) (STO:NGS) Shares Have Insiders Sold, In The Last Year?
Dec 28
NGS Group (STO:NGS) Has A Pretty Healthy Balance Sheet
Nov 30Revenue & Expenses BreakdownBeta
How NGS Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 459 | -129 | 18 | 0 |
| 31 Dec 23 | 500 | -126 | 19 | 0 |
| 30 Sep 23 | 541 | -122 | 22 | 0 |
| 30 Jun 23 | 561 | -13 | 22 | 0 |
| 31 Mar 23 | 576 | -3 | 21 | 0 |
| 31 Dec 22 | 571 | 4 | 18 | 0 |
| 30 Sep 22 | 558 | 8 | 15 | 0 |
| 30 Jun 22 | 538 | 17 | 14 | 0 |
| 31 Mar 22 | 525 | 17 | 14 | 0 |
| 31 Dec 21 | 496 | 13 | 13 | 0 |
| 30 Sep 21 | 464 | 12 | 12 | 0 |
| 30 Jun 21 | 449 | 10 | 11 | 0 |
| 31 Mar 21 | 425 | 7 | 10 | 0 |
| 31 Dec 20 | 432 | 8 | 10 | 0 |
| 30 Sep 20 | 458 | 8 | 12 | 0 |
| 30 Jun 20 | 479 | 9 | 12 | 0 |
| 31 Mar 20 | 516 | 10 | 13 | 0 |
| 31 Dec 19 | 549 | 14 | 15 | 0 |
| 30 Sep 19 | 576 | 19 | 18 | 0 |
| 30 Jun 19 | 593 | 20 | 21 | 0 |
| 31 Mar 19 | 608 | 28 | 23 | 0 |
| 31 Dec 18 | 625 | 28 | 25 | 0 |
| 30 Sep 18 | 656 | 38 | 23 | 0 |
| 30 Jun 18 | 682 | 42 | 23 | 0 |
| 31 Mar 18 | 692 | 41 | 21 | 0 |
| 31 Dec 17 | 683 | 43 | 20 | 0 |
| 30 Sep 17 | 659 | 35 | 18 | 0 |
| 30 Jun 17 | 641 | 35 | 17 | 0 |
| 31 Mar 17 | 628 | 35 | 18 | 0 |
| 31 Dec 16 | 619 | 35 | 18 | 0 |
| 30 Sep 16 | 597 | 30 | 20 | 0 |
| 30 Jun 16 | 574 | 28 | 19 | 0 |
| 31 Mar 16 | 552 | 28 | 17 | 0 |
| 31 Dec 15 | 535 | 28 | 16 | 0 |
| 30 Sep 15 | 522 | 31 | 13 | 0 |
| 30 Jun 15 | 517 | 33 | 13 | 0 |
| 31 Mar 15 | 504 | 32 | 12 | 0 |
| 31 Dec 14 | 491 | 30 | 12 | 0 |
| 30 Sep 14 | 481 | 28 | 12 | 0 |
| 30 Jun 14 | 475 | 27 | 13 | 0 |
| 31 Mar 14 | 450 | 27 | 12 | 0 |
| 31 Dec 13 | 393 | 25 | 11 | 0 |
| 30 Sep 13 | 328 | 21 | 9 | 0 |
| 30 Jun 13 | 261 | 16 | 7 | 0 |
Quality Earnings: NGS is currently unprofitable.
Growing Profit Margin: NGS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NGS is unprofitable, and losses have increased over the past 5 years at a rate of 77.9% per year.
Accelerating Growth: Unable to compare NGS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NGS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.4%).
Return on Equity
High ROE: NGS has a negative Return on Equity (-118.62%), as it is currently unprofitable.